Effect of Key Baseline Disease Characteristics on Aflibercept 8 mg Dosing Interval Extension: A Post Hoc 96-Week Analysis of PULSAR

Ophthalmology Retina · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles